About Enigma
We believe your biology is yours.
Not the hospital's. Not the insurer's. Not a tech company's. Yours. That belief is the beginning of everything Enigma does.
What We Build
256-bit
AES Encryption
Zero
Knowledge Proofs
Post
Quantum Safe
100%
User Owned
Why we are building this.
The healthcare system in the United States spends more per person than any country on earth and produces outcomes that rank below thirty other nations. It is not for lack of medical knowledge. We understand more about human biology today than at any point in history. We can sequence a full genome in hours. We can detect cancer at the molecular level before a single symptom appears. We know which genetic markers predict disease decades before onset.
The problem is the infrastructure. The record that contains the most important information about your health is owned by whoever treated you last. It cannot follow you between providers. It is encrypted with technology that will be breakable within a decade. And the system that is supposed to protect you — your insurer — has a direct financial incentive to deny your claims, delay your care, and wait for you to give up.
We built Enigma to change the architecture, not to negotiate with the existing one. A quantum-safe vault that is mathematically yours. A consent system that gives you genuine control over every access to your record. An insurance model that aligns financial incentives with keeping you healthy rather than with denying your claims. And a research network that compensates you for the scientific value of your biology — on your terms.
The Team

Kenneth Clark
Co-Founder & CEO
Ken has spent his career on one problem: finding the infrastructure failure underneath an expensive, recurring dysfunction — and building the system that makes it structurally impossible. He has run organizations at scale, led transformations that eliminated millions in redundant process, and built governed platforms that replaced fragmented, institution-by-institution workflows with unified systems.
Based in Rochester, NY | ken@enigmagenetics.com

William Tobelaim
Co-Founder, Cryptography & Systems Architecture
William builds systems that protect what is most private. His work sits at the intersection of cryptography, secure computation, and the architecture of trust. He implements zero-knowledge proofs, post-quantum encryption, and hardware-secured computation environments where data can be queried without ever being exposed.
wtobelaim@enigmagenetics.com

Dr. Carrie Huffman, RAC-US
Regulatory Strategy Advisor
Dr. Huffman advises on clinical research operations, regulatory compliance, and trial execution to ensure seamless integration into real-world study workflows. She supports IRB alignment, QA frameworks, and clinical system integration to ensure infrastructure is audit-ready, protocol-aligned, and deployable across multi-site trials and healthcare environments. A strategic leader in the medical device industry with expertise in regulatory and clinical affairs, she brings decades of experience as a policy observer and advocate.
Regulatory & Clinical Affairs Consultant | Contract Advisor
Current Stage
Stealth
We are in the early stage. The infrastructure is being built. The partnerships are being formed. The regulatory framework is being shaped. If you believe that your biology is yours — that the record of your health should follow you, protect you, and work for you — then join us now, while the architecture is still being written.
Our Principles
Your biology is your most fundamental data. It is more personal than your financial records, more enduring than your communications, and more consequential than any other information you could share.
Consent must be real. Not a checkbox. Not buried in a terms-of-service agreement. A genuine, informed decision — with a clear explanation of what you are sharing, why, and what the implications are.
The system's incentives are broken. Insurance companies profit from denial. Hospitals profit from fragmentation. Enigma is designed to change the alignment — not to ask nicely.
Early detection saves lives. The difference between Stage 1 and Stage 4 is not a medical question — it is an infrastructure question. That is the gap Enigma closes.
Long-lived data needs long-lived protection. Enigma uses post-quantum cryptography that will still be secure when quantum computers are commonplace.